Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report von Xie, Xiaobo, Chen, Jinzhang, Song, Hongli, Fan, Zebin

Volltext

MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer von Liu, Feiye, Cai, Yanjun, Rong, Xiaoxiang, Chen, Jinzhang, Zheng, Dayong, Chen, Lu, Zhang, Junyi, Luo, Rongcheng, Zhao, Peng, Ruan, Jian

Volltext

Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients von Yuan, Guosheng, Song, Yangda, Li, Qi, Hu, Xiaoyun, Zang, Mengya, Dai, Wencong, Cheng, Xiao, Huang, Wei, Yu, Wenxuan, Chen, Mian, Guo, Yabing, Zhang, Qifan, Chen, Jinzhang

Volltext

Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis von Hu, Xiaoyun, Li, Rong, Li, Qi, Zang, Mengya, Yuan, Guosheng, Chen, Jinzhang

Volltext

DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway von Hu, Xiaoyun, Yuan, Guosheng, Li, Qi, Huang, Jing, Cheng, Xiao, Chen, Jinzhang

Volltext

Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial von Xu, Li, Chen, Jinzhang, Liu, Chang, Song, Xiaoling, Zhang, Yanqiao, Zhao, Haitao, Yan, Sheng, Jia, Weidong, Wu, Zheng, Guo, Yabing, Yang, Jiayin, Gong, Wei, Ma, Yue, Yang, Xiaobo, Gao, Zhenzhen, Zhang, Nu, Zheng, Xin, Li, Mengyu, Su, Dan, Chen, Minshan

Volltext

Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study von Li, Qi, Cao, Mengran, Yuan, Guosheng, Cheng, Xiao, Zang, Mengya, Chen, Ming, Hu, Xiaoyun, Huang, Jing, Li, Rong, Guo, Yabing, Ruan, Jian, Chen, Jinzhang

Volltext

Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysi... von Yuan, Guosheng, Xie, Fuli, Song, Yangda, Li, Qi, Li, Rong, Hu, Xiaoyun, Zang, Mengya, Cheng, Xiao, Lu, Guanting, Huang, Jing, Fan, Wenzhe, Rong, Xiaoxiang, Sun, Jian, Chen, Jinzhang

Volltext

Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β2‐AR/MACC1 axis von Pan, Changqie, Wu, Jianhua, Zheng, Siting, Sun, Huiying, Fang, Yisheng, Huang, Zhenhua, Shi, Min, Liang, Li, Bin, Jianping, Liao, Yulin, Chen, Jinzhang, Liao, Wangjun

Volltext

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma von Chen, Jinzhang, Rong, Xiaoxiang, Liu, Xinhui, Zheng, Dayong, Rong, Xiaodong, Chen, Fengsheng, Zhao, Peng, Liu, Feiye, Ruan, Jian

Volltext

Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma von Cheng, Yang, Luo, RongCheng, Zheng, Hang, Wang, Biao, Liu, YaHui, Liu, DingLi, Chen, JinZhang, Xu, WanFu, Li, AiMin, Zhu, Yun

Volltext

A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma von Zhu, Wei, Zhang, Zhiming, Chen, Jinzhang, Chen, Xiaolan, Huang, Lei, Zhang, Xiaoyong, Huang, Xuan, Ma, Na, Xu, Weikang, Yi, Xuan, Lu, Xinyu, Fu, Xin, Li, Siwei, Mo, Guoheng, Wang, Yiyue, Yuan, Guosheng, Zang, Mengya, Li, Qi, Jiang, Xiaotao, He, Yajing, Wu, Sha, He, Yukai, Li, Yongyin, Hou, Jinlin

Volltext

Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity sco... von Yuan, Guosheng, Li, Wenli, Zang, Mengya, Li, Rong, Li, Qi, Hu, Xiaoyun, Zhang, Qi, Huang, Wei, Ruan, Jian, Pang, Huajin, Chen, Jinzhang

Volltext

Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma von Shen, Yifei, Xu, Shuaishuai, Ye, Chanqi, Li, Qiong, Chen, Ruyin, Wu, Wei, Jiang, Qi, Jia, Yunlu, Zhang, Xiaochen, Fan, Longjiang, Fu, Wenguang, Jiang, Ming, Chen, Jinzhang, Timko, Michael P., Zhao, Peng, Ruan, Jian

Volltext

Silencing TRPC1 expression inhibits invasion of CNE2 nasopharyngeal tumor cells von He, Benfu, Liu, Feiye, Ruan, Jian, Li, Aimin, Chen, Jinzhang, Li, Rong, Shen, Jie, Zheng, Dayong, Luo, Rongcheng

Volltext

The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma von Zuo, Qiang, Shi, Min, Chen, Jinzhang, Liao, Wangjun

Volltext

Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study) von Chen, Jinzhang, Zang, Mengya, Pang, Huajin, Li, Chuanjiang, Zhao, Jianbo, Guo, Yabing, Hou, Jinlin

Volltext

Development of cetuximab-resistant human nasopharyngeal carcinoma cell lines and mechanisms of drug resistance von Zuo, Qiang, Shi, Min, Li, Libo, Chen, Jinzhang, Luo, Rongcheng

Volltext

Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin fo... von Zang, Mengya, Hu, Xiaoyun, Yuan, Guosheng, Li, Rong, Li, Wenli, Pang, Huajin, Li, Qi, Chen, Jinzhang

Volltext

Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective... von Zang, Mengya, Li, Qi, Hu, Xiaoyun, Yuan, Guosheng, Li, Rong, Guo, Yabing, Chen, Jinzhang

Volltext